El uso de frmacos anlogos del GLP-1 est asociado con beneficios pero tambin riesgos para la salud El uso de agonistas del receptor del pptido similar al glucagn tipo 1 (GLP-1RAs, por sus siglas en ingls), utilizados para tratar la diabetes y la obesidad, podra estar asociado con un amplio espectro de efectos sobre la salud, tanto positivos como un menor riesgo de trastornos cardiometablicos como negativos un mayor riesgo de afecciones gastrointestinales o hipertensin
The analytical performance of the fabricated sensor scheme with and without graphene oxide and/or copper nanoparticles was determined from direct glutathione injections during an amperometry analysis
PD-1/PD-L1 as a prognostic factor in leukemia
While the GR inhibitor M 5 [38,39] had no effect on TGR, naphthazarin and its derivatives JD155 and JD159 [36] inhibited TGR, but not selectively
Your account will be charged for renewal within 24 hours prior to the end of the current period
Conclusions : This case highlights the potential role of GLP-1 receptor agonist in assisting in patients who experience weight gain associated with Tamoxifen therapy for breast cancer